Deaths in the leronlimab arm count as deaths in th
Post# of 147640
The assumption is that people are going to die and that leronlimab has the opportunity to prevent deaths. If the patient died, leronlimab did not prevent the death as hoped and expected.
This is why the important metric is the reduction in mortality rate, with most the predominant expectation that leronlimab will have a 50% reduction in death rate.